Ionis Pharmaceuticals Inc. Common Stock vs Rollins Inc. Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Rollins Inc. Common Stock trades at $32.61 (market cap $15.47B). The key difference: Rollins Inc. Common Stock is far larger — about 2.2× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Rollins Inc. Common Stock pays a 2.27% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Rollins Inc. Common Stock for 0 Days on average.
| IONS | ROL | |
|---|---|---|
Market Cap | $7.04B | $15.47B |
Volume | 2,977,440 | 6,712,154 |
Sector | Health | Industrials |
52-Week High | $86.50 | $65.60 |
52-Week Low | $42.38 | $29.69 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $16.48B |
Dividend Yield | — | 2.27% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Rollins Inc. provides pest control services to residential and commercial customers through its family of brands, including Orkin, across dozens of countries.
Read more on ROL →